YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Beta Bionics, Inc. BBNX recently announced a partnership with Senseonics SENS to expand compatibility between its automated insulin delivery (AID) platform and Senseonics' continuous glucose monitoring technology. The collaboration is expe…
[Wall Street New York stock exchange stock market] alexsl Several sub-$10 stocks are flashing elevated momentum signals, with a handful already entering traditionally overbought territory as recent rallies push their Relative Strength Inde…
DexCom, Inc. DXCM is entering the second half of 2026 with healthier margins, broader reimbursement and a larger continuous glucose monitoring opportunity. The investment question is whether that improving setup is enough to justify a prem…
DexCom DXCM stock has rebounded sharply in 2026, gaining 34.8% after falling 14.7% in 2025, as investors increasingly recognize the company's improving growth profile and expanding continuous glucose monitoring (CGM) opportunity. The compa…
DexCom, Inc. DXCM raised its 2026 revenue and margin outlook after a stronger second quarter, shifting more attention toward profitability. The question is whether better gross margin and operating leverage can persist as organic growth im…
Omnicell (OMCL) came out with quarterly earnings of $0.94 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.45 per share a year ago. These figures are adjusted for non-recurring items. This…
By Karen Roman Glucotrack, Inc. (Nasdaq: GCTK) said the US Patent and Trademark Office issued a Notice of Allowance for a patent application which expands the intellectual property protecting the company's continuous blood glucose monitori…
Senseonics Holdings SENS shares soared 6.1% in the last trading session to close at $5.72. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 19.8% loss over the p…
Senseonics SENS recently entered into a strategic partnership with Welldoc to develop a next-generation mobile application for its Eversense 365 continuous glucose monitoring (CGM) system. The new app is expected to enhance the user experi…
As European markets grapple with mixed signals, including a recent contraction in the eurozone economy and fluctuating retail sales, investors are increasingly focused on identifying resilient growth opportunities. In such an environment,…
Eversense 365 delivered favorable glucometrics compared to other open and closed loop systems, validating the one-year CGM’s differentiated approach and high performance New data expands on findings shared at ATTD and reinforces Eversense…
As global markets navigate geopolitical developments and economic shifts, Asia's growth landscape continues to capture investor interest with its blend of technological advancement and consumer demand. In this environment, companies with h…
[Health Care sector, stock exchange monitor with index information.] Torsten Asmus The semi-annual rebalancing of U.S. equities is officially underway after FTSE Russell unveiled its preliminary list of shifts for the broad-market Russell…
Image source: The Motley Fool. DATE Thursday, May 7, 2026 at 4:30 p.m. ET CALL PARTICIPANTS President & Chief Executive Officer — Tim Goodnow Chief Operating Officer — Brian Hansen Chief Financial Officer — Frederick Sullivan Chief Medical…
Senseonics Holdings (SENS) came out with a quarterly loss of $0.71 per share versus the Zacks Consensus Estimate of a loss of $0.65. This compares to a loss of $0.4 per share a year ago. These figures are adjusted for non-recurring items.…
* Senseonics Holdings (NYSE: SENS [https://seekingalpha.com/symbol/SENS]) on Monday said it has amended its loan and security agreement with Hercules Capital (HTGC [https://seekingalpha.com/symbol/HTGC]) to increase total borrowing capacit…
Senseonics Holdings, Inc. GERMANTOWN, Md., May 04, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the design, development and commercialization of glucose monitoring products desig…
BayFirst Financial's (BAFN) shares sank 28% after the company reported a wider Q1 loss and lower rev PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
GERMANTOWN, Md., May 01, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the development, manufacturing and commercialization of long-term, implantable continuous glucose monitoring…
GERMANTOWN, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the development, manufacturing and commercialization of long-term, implantable continuous glucose monitor…
Senseonics SENS recently announced the European launch of its groundbreaking Eversense 365 CGM system, the world’s first continuous glucose monitoring (CGM) system designed to last an entire year. Following CE mark approval in January 2026…
(RTTNews) - Senseonics Holdings, Inc. (SENS) has begun rolling out its next-generation Eversense 365 system in Europe, marking the arrival of the world's first and only continuous glucose monitor (CGM) designed to last a full year. A small…
By Karen Roman GlucoTrack, Inc. (Nasdaq: GCTK) said a peer-reviewed study published in the Institute of Electrical and Electronics Engineers Sensors Journal supported the feasibility of long-life implantable continuous glucose monitors lik…
Senseonics Holdings, Inc. SENS recently presented first-ever real-world evidence for its Eversense 365 continuous glucose monitoring (CGM) system at the ATTD conference, highlighting strong performance across a full year of use. From an in…
Senseonics Holdings, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Transformation and Operational Control Transitioned from a partnered model with Ascensia to a fully integrated developer, manufacturer, and direct seller to gain agil…
(RTTNews) - Senseonics Holdings, Inc. (SENS), a commercial-stage medical technology company, reported fourth-quarter and full-year results with revenue growth. The company expects full year 2026 revenue to increase by 65 to 76 percent. Fou…
Earnings Call Insights: Senseonics Holdings, Inc. (SENS) Q4 2025 MANAGEMENT VIEW * Tim Goodnow, President and CEO, highlighted that "2025 was certainly a year of transformation at Senseonics," citing the transition to a fully integrated de…
Image source: The Motley Fool. Date Monday, March 2, 2026 at 4:30 p.m. ET Call participants President and Chief Executive Officer — Timothy T. Goodnow Chief Financial Officer — Frederick T. Sullivan Chief Commercial Officer — Brian Hansen…
Major earnings expected after the bell on Monday include: * Plug Power (PLUG [https://seekingalpha.com/symbol/PLUG]) * Archer Aviation (ACHR [https://seekingalpha.com/symbol/ACHR]) * Credo Technology Group Holding Ltd (CRDO [https://seekin…
* Senseonics (SENS [https://seekingalpha.com/symbol/SENS]) is scheduled to announce Q4 earnings results on Monday, March 2nd, after market close. * The consensus EPS Estimate is -$0.43 [https://seekingalpha.com/symbol/SENS/earnings/estimat…
Enovis (ENOV) came out with quarterly earnings of $0.95 per share, beating the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $0.98 per share a year ago. These figures are adjusted for non-recurring items. This q…
Senseonics SENS recently announced the full availability of its long-term, implantable Continuous Glucose Monitoring (CGM) system, Eversense 365, integrated with Sequel Med Tech’s twiist Automated Insulin Delivery (AID) system for U.S. pat…
As global markets navigate a landscape marked by AI disruption concerns and robust U.S. job gains, major indices like the Nasdaq Composite have experienced notable declines, reflecting broader market sentiment. Amidst this backdrop, identi…
Senseonics Holdings, Inc. SENS recently scored a meaningful regulatory win in Europe, receiving CE Mark approval for its Eversense 365 continuous glucose monitoring (CGM) system. The approval builds on the U.S. launch momentum of Eversense…
The European market has shown resilience, with the pan-European STOXX Europe 600 Index rising by 0.77%, supported by strong economic data and earnings results, despite mixed performances among major stock indexes. In this environment of ca…
Senseonics Holdings, Inc. SENS recently reached an important commercialization milestone with the launch of its Eversense 365 continuous glucose monitor (CGM) integrated with the twiist automated insulin delivery (AID) system. The company…